LigaChem Biosciences said Tuesday that its U.K. partner, Iksuda Therapeutics, has received U.S. FDA approval to expand its ...

Gilead Sciences just hit Korea’s accelerator with Livdelzi (seladelpar) -- and Ipsen’s rival Iqirvo (elafibranor) may be ...

Ybrain's MINDD STIM, a device-based antidepressant treatment, has received a two-year extension under Korea’s new medical ...

ST Pharm announced said it has signed two new supply contracts worth a combined $18.25 million (24.9 billion won) with two ...

Dong-A ST said it has entered into a co-promotion agreement with Ipsen Korea for Diphereline (ingredient: triptorelin), a ...

Korean researchers have proposed a new treatment strategy for glioblastoma, an incurable brain tumor that does not respond to ...

Samsung Bioepis and Hanmi Pharmaceutical on Tuesday jointly launched Obodense (ingredient: denosumab), a biosimilar ...

Astellas Korea, the Korean affiliate of global life sciences company Astellas Pharma, said it has named former Daiichi Sankyo ...

The structure of hospital care is evolving. With patient safety, quality of care, and sustainable healthcare systems becoming ...

In April, South Korea became the first country in the world to pass a standalone synthetic-biology law, effectively signing a ...

Celltrion Pharm said it has launched Nesina Met Extended-Release (XR) tablets, a fixed-dose combination treatment for type 2 ...

After President Lee Jae Myung nominated Jeong Eun-kyeong, former commissioner of the Korea Disease Control and Prevention ...